logo

Beam Therapeutics Inc. (BEAM)



Trade BEAM now with
  Date
  Headline
8/3/2020 2:03:34 AM Oxford Biomedica Signs Development, Manufacture & License Agreement With Beam Therapeutics
6/29/2020 8:01:16 PM Wedbush Reiterates Beam Therapeutics Inc. (BEAM) At Outperform With $32 Price Target
6/15/2020 6:04:25 AM Magenta, Beam Therapeutics Announce Non-exclusive Collaboration Agreement To Evaluate Potential Utility Of MGTA-117
5/13/2020 8:19:29 AM Wedbush Is Cutting Beam Therapeutics Inc. (BEAM) FY21 Estimate To -2.13 From -1.92
5/13/2020 8:19:16 AM Wedbush Is Cutting Beam Therapeutics Inc. (BEAM) Q4 21 Estimate To -0.49 From -0.41
5/13/2020 8:17:14 AM Wedbush Is Cutting Beam Therapeutics Inc. (BEAM) Q3 21 Estimate To -0.46 From -0.43
5/13/2020 8:16:59 AM Wedbush Is Cutting Beam Therapeutics Inc. (BEAM) Q2 21 Estimate To -0.58 From -0.55
5/13/2020 8:16:37 AM Wedbush Is Cutting Beam Therapeutics Inc. (BEAM) Q1 21 Estimate To -0.61 From -0.53
5/13/2020 8:16:19 AM Wedbush Is Lowering Beam Therapeutics Inc. (BEAM) FY20 Estimate To -2.48 From -1.88
5/13/2020 8:16:05 AM Wedbush Is Cutting Beam Therapeutics Inc. (BEAM) Q4 20 Estimate To -0.55 From -0.47
5/13/2020 8:15:51 AM Wedbush Is Lowering Beam Therapeutics Inc. (BEAM) Q3 20 Estimate To -0.54 From -0.46
5/13/2020 8:15:38 AM Wedbush Is Lowering Beam Therapeutics Inc. (BEAM) Q2 20 Estimate To -0.53 From -0.46
5/13/2020 8:15:16 AM Wedbush Reiterates Beam Therapeutics Inc. (BEAM) At Outperform With $32 Price Target
3/2/2020 7:26:11 AM Wedbush Initiates Beam Therapeutics Inc. (BEAM) At Outperform With $32 Price Target
2/11/2020 7:43:44 AM Beam Therapeutics Reports Closing Of IPO Of 12.18 Mln Shares Of Common Stock
2/11/2020 6:34:36 AM Beam Therapeutics Announces Continued Progress In Evolution Of its Novel ABE And Cytosine Base Editor Technologies
2/5/2020 7:35:54 PM Beam Therapeutics Prices IPO Of 10.59 Mln Shares At $17.00/shr